Nova Leap Health Corp. (TSXV:NLH) announced a brokered private placement on a best efforts basis, of a minimum of 5,000,000 units and a maximum of 8,000,000 units at a price of CAD 0.25 per unit for minimum gross proceeds of CAD 1,250,000 and maximum gross proceeds of CAD 2,000,000 on January 19, 2018. Each unit consists of one common share and one half of one common share purchase warrant. Each warrant entitles the holder thereof to purchase one additional common share of the company at a price of CAD 0.375 for a period of 24 months from the closing date. The agent has been granted the option to sell up to an additional 2,000,000 units at any time up to 48 hours prior to the closing. The closing is expected to occur on or before February 16, 2018, and is subject to the receipt of all necessary regulatory approvals including the approval of the TSX Venture Exchange. All securities will be subject to a four month hold period.